Testing Status of Vanadium pentoxide 10306-Y
CASRN: 1314-62-1
Related: Vanadium dioxide
Formula: O5-V2
Synonyms/Common Names
- Vanadium oxide (9CI)
Short-Term Toxicity
- 2 weeks (Inhalation)
(C61427)
Completed
- Rats: F344/N; Mice: B6C3F1
- Dose: R&M: 0.0, 2.0, 4.0, 8.0, 16.0 OR 32.0 MG/M3 (5/S/S).
- 2 weeks (Inhalation)
(C61427B)
Completed
- Rats: F344/N; Mice: B6C3F1
- Dose: FR: 0, 1, 2, OR 4 MG/M3 FM: 0, 2, 4, OR 8 MG/M3; 60/SPECIES/GROUP.
- 13 weeks (Inhalation)
(C61427)
Completed
- Rats: F344/N; Mice: B6C3F1
- Dose: R&M: 0.0, 1.0, 2.0, 4.0, 8.0, OR 16 MG/M3 (10/S/S).
Long-Term Carcinogenicity
- 2 years (Inhalation)
(C61427B)
Completed
- TR-507 (NIH Number: 03-4441)
(Peer Review Approval 10/18/2001A )
Toxicology and Carcinogenesis Studies of Vanadium Pentoxide (CASRN 1314-62-1) in F344/N Rats and B6C3F1 Mice (Inhalation Studies) - Rats: F344/N; Mice: B6C3F1
- Carcinogenesis Results
- Male Rats Some Evidence
- Female Rats Equivocal Evidence
- Male Mice Clear Evidence
- Female Mice Clear Evidence
- Dose: R: 0, 0.5, 1, OR 2 MG/M3 M: 0, 1, 2, OR 4 MG/M3; 70/SEX/SPECIES/GROUP.
- TR-507 (NIH Number: 03-4441)
(Peer Review Approval 10/18/2001A )
Special Studies
- Toxicokinetic Study (Inhalation)
(S0607)
Completed
- Male and Female Rats: F344/N; Male and Female Mice: B6C3F1
- Dose: 14d: FR: 1, 2, 4 mg/m3; FM: 2, 4, 8 mg/m3 (report 08/96) 104w: R: 0.5, 1, 2 mg/m3; M: 1, 2, 4 mg/m3.
Genetic Toxicology
- Micronucleus
(A59682)
Completed
- Mice: B6C3F1
- Male Negative
- Female Negative
- Salmonella
(523108)
Completed
- Negative
Organ Systems Toxicity
- Immunotoxicity (Inhalation)
(S0001)
Completed
- Monkeys